Intrexon reported $-25469000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN -292000000 1.38B
Bluebird Bio BLUE:US $ -135.67M 81.29M
Immunogen IMGN:US $ -22.85M 11.7M
Intrexon XON:US $ -25.47M 9.8M
Novartis NOVN:VX 2.56B 671M
Peregrine Pharmaceuticals PPHM:US $ 4.15M 2.78M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Xencor XNCR:US $ 26.47M 65.19M
Ziopharm Oncology ZIOP:US $ -9085000 1.97M